Phosphoproteomic analysis of the AKT signalling axis in cutaneous squamous carcinoma progression reveals novel therapeutic targets
R. Button, C. Harwood, R. F. O'Shaughnessy
This study identifies novel therapeutic targets in cutaneous squamous cell carcinoma by analyzing AKT signaling dynamics and phosphoproteomic changes across disease stages.
bioRxiv · Oct 3, 2022 · PreprintCancer Biology